IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cellsviathe STAT3 pathway in colon cancer-Reference-Cited by-同舟云学术

IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cellsviathe STAT3 pathway in colon cancer

Published:2016-01-25 Issue:6 Volume:7 Page:7307-7317
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bak Yesol¹²,Kwon Taeho¹²,Bak In seon²,Hong Jintae³,Yu Dae-Yeul²,Yoon Do-Young¹

Affiliation:

1. Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Seoul, Korea

2. Disease Model Research Laboratory, Aging Intervention Research Center, Development and Differentiation Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea

3. College of Pharmacy, Chungbuk National University, Cheongju, Chungbuk, Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant Human IL-32θ Induces Polarization Into M1-like Macrophage in Human Monocytic Cells;Immune Network;2024

2. IL-32 and its paradoxical role in neoplasia;Critical Reviews in Oncology/Hematology;2023-06

3. Human IL-32θA94V mutant attenuates monocyte-endothelial adhesion by suppressing the expression of ICAM-1 and VCAM-1 via binding to cell surface receptor integrin αVβ3 and αVβ6 in TNF-α-stimulated HUVECs;Frontiers in Immunology;2023-05-09

4. Comparison of the Seven Interleukin-32 Isoforms’ Biological Activities: IL-32θ Possesses the Most Dominant Biological Activity;Frontiers in Immunology;2022-02-25

5. A Paradoxical Effect of Interleukin-32 Isoforms on Cancer;Frontiers in Immunology;2022-02-25